Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes.

Drug testing and analysis

Kiousi P, Fragkaki AG, Kioukia-Fougia N, Angelis YS.
PMID: 33942526
Drug Test Anal. 2021 May 03; doi: 10.1002/dta.3056. Epub 2021 May 03.

Intact phase II steroid metabolites have poor product ion mass spectra under collision-induced dissociation (CID) conditions. Therefore, we present herein the liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/(MS)) behavior of intact phase II metabolites of oxosteroids after derivatization. Based on...

Cite
Kiousi P, Fragkaki AG, Kioukia-Fougia N, et al. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Test Anal. 2021;doi: 10.1002/dta.3056.
Kiousi, P., Fragkaki, A. G., Kioukia-Fougia, N., & Angelis, Y. S. (2021). Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug testing and analysis, . https://doi.org/10.1002/dta.3056
Kiousi, Polyxeni, et al. "Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes." Drug testing and analysis vol. (2021). doi: https://doi.org/10.1002/dta.3056
Kiousi P, Fragkaki AG, Kioukia-Fougia N, Angelis YS. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Test Anal. 2021 May 03; doi: 10.1002/dta.3056. Epub 2021 May 03. PMID: 33942526.
Copy Download .nbib Format: NLM
ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne.

Dermato-endocrinology

Rocha M, Cardozo KHM, Carvalho VM, Bagatin E.
PMID: 29497466
Dermatoendocrinol. 2017 Oct 13;9(1):e1361571. doi: 10.1080/19381980.2017.1361571. eCollection 2017.

Acne vulgaris is a chronic inflammatory disease that affects the pilosebaceous unit. Recent studies have shown an increasing number of cases of acne in adult women. These cases are predominantly normoandrogenic and present some clinical differences compared to adolescent...

Cite
Rocha M, Cardozo KHM, Carvalho VM, et al. ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne. Dermatoendocrinol. 2017;9(1):e1361571doi: 10.1080/19381980.2017.1361571.
Rocha, M., Cardozo, K. H. M., Carvalho, V. M., & Bagatin, E. (2017). ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne. Dermato-endocrinology, 9(1), e1361571. https://doi.org/10.1080/19381980.2017.1361571
Rocha, Marco, et al. "ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne." Dermato-endocrinology vol. 9,1 (2017): e1361571. doi: https://doi.org/10.1080/19381980.2017.1361571
Rocha M, Cardozo KHM, Carvalho VM, Bagatin E. ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne. Dermatoendocrinol. 2017 Oct 13;9(1):e1361571. doi: 10.1080/19381980.2017.1361571. eCollection 2017. PMID: 29497466; PMCID: PMC5823034.
Copy Download .nbib Format: NLM
Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes.

Drug testing and analysis

Kiousi P, Fragkaki AG, Kioukia-Fougia N, Angelis YS.
PMID: 33942526
Drug Test Anal. 2021 Nov;13(11):1822-1834. doi: 10.1002/dta.3056. Epub 2021 May 16.

Intact phase II steroid metabolites have poor product ion mass spectra under collision-induced dissociation (CID) conditions. Therefore, we present herein the liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/(MS)) behavior of intact phase II metabolites of oxosteroids after derivatization. Based on...

Cite
Kiousi P, Fragkaki AG, Kioukia-Fougia N, et al. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Test Anal. 2021;13(11):1822-1834doi: 10.1002/dta.3056.
Kiousi, P., Fragkaki, A. G., Kioukia-Fougia, N., & Angelis, Y. S. (2021). Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug testing and analysis, 13(11), 1822-1834. https://doi.org/10.1002/dta.3056
Kiousi, Polyxeni, et al. "Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes." Drug testing and analysis vol. 13,11 (2021): 1822-1834. doi: https://doi.org/10.1002/dta.3056
Kiousi P, Fragkaki AG, Kioukia-Fougia N, Angelis YS. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Test Anal. 2021 Nov;13(11):1822-1834. doi: 10.1002/dta.3056. Epub 2021 May 16. PMID: 33942526.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries